Research Project
Grant-in-Aid for Young Scientists (B)
We examined the tumor-infiltrating DC subsets with the potential to migrate to draining-lymph nodes and identified CCR7^+ MHC class II^<hi> TIDCs as the precursor of lymph node migratory DCs with antigen uptake and presentation potential. Chemokine receptor KO (CKO) mice and the wild type vs CKO mixed bone marrow chimera mice revealed that CCR2 partially mediates the accumulation of the TIDCs. We also found that the TIDCs were relatively resistant to the anti-cancer drug in vivo. Based on these results, we expect that the combination therapy of anti-cancer drug and CCR2 targeted drug that augment TIDCs would provide a novel anti-cancer immunotherapy.
All 2011 2010 2009 Other
All Journal Article (10 results) (of which Peer Reviewed: 10 results) Presentation (30 results) Book (4 results) Remarks (1 results)
Int Immunopharmacol. 掲載確定(印刷中)
Int Immunopharmacol
Volume: (掲載確定 in press)
Clin Exp Nephrol. 14
Pages: 411-417
J Biol Chem. 285
Pages: 28826-28837
Blood. 115
Pages: 5401-5411
Biochem Biophys Res Commun. 392
Pages: 217-222
Clin Exp Nephrol
Volume: 14 Pages: 411-417
J Biol Chem.
Volume: 285 Pages: 28826-28837
Blood
Volume: 115 Pages: 5401-5411
Biochem Biophys Res Commun 392
http://www.prevent.m.u-tokyo.ac.jp/